Entering text into the input field will update the search result below

Pfizer acquisition of Trillium Therapeutics completed

Nov. 17, 2021 10:20 AM ETPfizer Inc. (PFE) StockTRILBy: Jonathan Block, SA News Editor5 Comments

Pfizer COVID-19 Vaccine Data Shows 90 Percent Effective Rate

David Dee Delgado/Getty Images News

  • Pfizer (PFE +1.5%) has formally completed the acquisition of Trillium Therapeutics (TRIL).
  • Pfizer agreed to buy Trillium in a $2.3B deal in late August.
  • Trillium has two lead candidates, TTI-622 and TTI-621.
  • TTI-622 is enrolling in a

Recommended For You

About PFE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PFE--
Pfizer Inc.